OSTX - OS Therapies Inc
1.84
-0.500 -27.174%
Share volume: 1,728,497
Last Updated: 05-07-2025
Pharmaceutical Products/Pharmaceutical Preparations:
-0.13%
PREVIOUS CLOSE
CHG
CHG%
$2.34
-0.50
-0.21%
View ratios
| Fiscal Date | 09-30-2024 | |
|---|---|---|
| Fiscal Quarter | Q3 2024 | |
| Report Date | 11-15-2024 | |
| Total revenue | 0.000 | |
| Cost of revenue | 0.000 | |
| Gross profit | 0.000 | |
| Operating expenses | 2.437 M | |
| Selling general and admin | 1.227 M | |
| Research and development | 1.210 M | |
| Total expenses | 2.437 M | |
| Operating income | -2.437 M | |
| Ebit | -2.437 M | |
| Pretax income | -2.875 M | |
| Income tax | 0.000 | |
| Net income basic | 0.000 | |
| Net income | -2.875 M | |
